To evaluate the impact of Roux-en-Y gastric bypass and omega-loop gastric bypass on specific hepatic and metabolic markers, as well as weight loss, in morbidly obese patients over the first 12 postoperative months.
Key Findings:
Both surgical techniques resulted in significant weight loss over 12 months.
Omega-loop gastric bypass showed promising initial results in terms of weight loss and safety.
Improvements in liver function markers, such as AST and ALT, were observed postoperatively in both groups.
Interpretation:
The study suggests that both Roux-en-Y and omega-loop gastric bypass are effective for weight loss and improving liver function, with omega-loop presenting as a viable alternative.
Limitations:
Small sample size may limit generalizability.
Short follow-up period of 12 months does not capture long-term outcomes.
Potential biases in patient selection may affect results.
Conclusion:
Both Roux-en-Y and omega-loop gastric bypass are effective in managing morbid obesity and improving metabolic parameters, warranting further studies with larger populations and longer follow-up to validate these findings.
by Renate Kruschitz, Maria Luger, Christian Kienbacher, Michael Trauner, Carmen Klammer, Karin Schindler, Felix B. Langer, Gerhard Prager, Michael Krebs, Bernhard Ludvik
